ANALISIS EFEKTIVITAS TERAPI HIPERTENSI MENGGUNAKAN AMLODIPIN-BISOPROLOL DIBANDINGKAN AMLODIPINRAMIPRIL DI RSUD IBU FATMAWATI SOEKARNO SURAKARTA TAHUN 2021

Afifah, Mei Dwi Eli (2022) ANALISIS EFEKTIVITAS TERAPI HIPERTENSI MENGGUNAKAN AMLODIPIN-BISOPROLOL DIBANDINGKAN AMLODIPINRAMIPRIL DI RSUD IBU FATMAWATI SOEKARNO SURAKARTA TAHUN 2021. Skripsi thesis, Universitas Setia Budi.

[img] Text
INTISARI ABSTRACT.pdf

Download (95kB)
[img] Text
BAB 2.pdf
Restricted to Repository staff only

Download (273kB) | Request a copy
[img] Text
BAB 3.pdf
Restricted to Repository staff only

Download (138kB) | Request a copy
[img] Text
COVER - BAB 1.pdf

Download (1MB)
[img] Text
BAB 5.pdf
Restricted to Repository staff only

Download (13kB) | Request a copy
[img] Text
BAB 4.pdf
Restricted to Repository staff only

Download (303kB) | Request a copy
[img] Text
DAFTAR PUSTAKA.pdf

Download (106kB)
[img] Text
LAMPIRAN.pdf

Download (683kB)
[img] Text
Mei Dwi Eli A_Lembar Pernyataan Bebas Perpus.pdf

Download (59kB)
[img] Text
Mei Dwi Eli Afifah_24185451A_SuratKeteranganTurnitin.pdf

Download (22kB)

Abstract

Hypertension is a health condition that is being faced all over the world. Hypertension is one of the biggest risk factors for morbidity and mortality in cardiovascular disease, and it affects health costs. The purpose of this study was to analyze the cost-effectiveness of the combination therapy of amlodipin-bisoprolol and amlodipin-ramipril in hypertension outpatients at the Surakarta District Hospital in 2021. This research was conducted using a cross-sectional study. This study was conducted at the in RSUD Fatmawati Soekarno Surakarta 2022. The sample in this study used purposive sampling with patients who met the inclusion criteria. Cost analysis is done by calculating medical costs directly from the hospital's point of view by calculating the ACER and ICER values to find out the most cost-effective therapy. The results showed that the amlodipine-bisoprolol combination therapy was more effective with a percentage of 87.09% compared to the amlodipine-ramipril combination of 78.78%. The average medical cost of amlodipine-bisoprolol therapy is Rp. Rp. 3.600.879 and amlodipine-ramipril therapy of Rp. 3.905.874. The amlodipinebisoprolol combination group obtained a low ACER score of Rp. 1.714.318 . Keywords: Hypertension, CEA, Amlodipine, Bisoprolol, Ramipril

Item Type: Thesis (Skripsi)
Uncontrolled Keywords: Hypertension, CEA, Amlodipine, Bisoprolol, Ramipril
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Fakultas Farmasi > Prodi S1 Farmasi
Depositing User: Tifany Nur Arfiana
Date Deposited: 30 Nov 2022 02:45
Last Modified: 30 Nov 2022 02:45
URI: http://repo.setiabudi.ac.id/id/eprint/5546

Actions (login required)

View Item View Item